Related Experiment Video
Updated: Aug 15, 2026

Single-cell RNA Sequencing and Analysis of Human Pancreatic Islets
Published on: July 18, 2019
Gene silencing in the endocrine pancreas mediated by short-interfering RNA
Sean P Bradley1, Cristiana Rastellini, Marco A da Costa
1Department of Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Objectives:
RNA interference as mediated by short-interfering RNA (siRNA) offers a nonviral means to silence genes in tissue; however, few data exist about gene therapy using siRNA in pancreas tissue. To determine if siRNA treatment could silence an endogenous gene in pancreatic islets, we developed a murine model using the endocrine pancreas.
Methods:
The insulin 2 (Ins2) gene was targeted with siRNA, and quantitative RT-PCR, fluorescent microscopy, and FACS were used to measure transcript levels and siRNA cellular uptake and transfection efficiency. Isolated pancreatic islets were transfected with siRNA in vitro using a liposomal delivery method in a dose titration (50-400 nM) or pooled from BALB/c mice having received siRNA (100 microg) via hydrodynamic tail vein injection.
Results:
The Ins2 transcript level was significantly reduced by 55% in vitro with FACS data showing a transfection efficiency over 45% with the 400 nM concentration. In vivo delivery of siRNA to pancreatic islets revealed a 33% reduction in Ins2 mRNA levels, although siRNA was able to be detected in 19% of isolated islet cells.
Conclusion:
We have successfully used RNA interference to silence an endogenous tissue-specific gene (Ins2) in pancreatic islets when transfected in vitro or administered in vivo.
Insights
Short-interfering RNA (siRNA) successfully silenced the Ins2 gene in pancreatic islets, demonstrating a novel gene therapy approach for endocrine pancreas research. This study highlights siRNA
Area of Science:
- Molecular Biology
- Gene Therapy
- Endocrinology
Background:
- RNA interference (RNAi) using short-interfering RNA (siRNA) is a nonviral gene silencing method.
- Limited data exist on siRNA applications in pancreatic tissue for gene therapy.
- Developing effective gene silencing in pancreatic islets is crucial for research and therapeutic strategies.
Purpose of the Study:
- To investigate the efficacy of siRNA in silencing an endogenous gene within pancreatic islets.
- To establish a murine model for studying siRNA-mediated gene therapy in the endocrine pancreas.
Main Methods:
- Targeted the insulin 2 (Ins2) gene using siRNA in isolated pancreatic islets.
- Utilized quantitative RT-PCR, fluorescent microscopy, and FACS to assess gene silencing and siRNA delivery.
- Administered siRNA via in vitro liposomal transfection and in vivo hydrodynamic tail vein injection in mice.
Main Results:
- In vitro, a 55% reduction in Ins2 transcript levels was achieved with 400 nM siRNA, showing over 45% transfection efficiency.
- In vivo, pancreatic islets showed a 33% decrease in Ins2 mRNA levels after siRNA administration.
- siRNA was detected in 19% of isolated islet cells following in vivo delivery.
Conclusions:
- Successfully demonstrated RNA interference for silencing the endogenous, tissue-specific Ins2 gene in pancreatic islets.
- Validated both in vitro and in vivo siRNA delivery methods for gene silencing in pancreatic islets.
- Provides a foundation for exploring siRNA-based gene therapy in pancreatic diseases.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...

